Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Overwrapping and Shrink-Wrapping – V 2.0

Posted on By

SOP for Overwrapping and Shrink-Wrapping – V 2.0

Procedure for Overwrapping and Shrink-Wrapping

Department Packaging/Quality Assurance (QA)/Production
SOP No. SOP/Ointment/095
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the proper method for performing overwrapping and shrink-wrapping of ointment packaging to ensure product protection, tamper evidence, and compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all personnel in the Packaging, Quality Assurance (QA), and Production departments responsible for overwrapping and shrink-wrapping finished ointment products.

3. Responsibilities

  • Packaging Operator: Conducts overwrapping and shrink-wrapping according to standard procedures.
  • Packaging Supervisor: Ensures correct setup, operation, and monitoring of wrapping equipment.
  • Quality Assurance (QA) Officer: Inspects wrapped products and ensures compliance with specifications.
  • QA Manager: Approves the final wrapped batch before distribution.
See also  Ointments: SOP for Homogeneity Testing at Different Stages - V 2.0

4. Accountability

The QA and Packaging Managers are accountable for ensuring overwrapping and shrink-wrapping operations comply with GMP and regulatory requirements.

5. Procedure

5.1 Pre-Wrapping Preparations

  • Ensure the packaging area is clean and free from previous batch materials.
  • Verify that the correct wrapping material (e.g., shrink film, overwrap) is available.
  • Check that the shrink-wrapping machine is properly calibrated and functional.

5.2 Overwrapping Process

  • Place finished ointment cartons in the designated overwrapping area.
  • Ensure that the correct wrapping material is used as per batch packaging
specifications.
  • Manually or mechanically wrap the batch with the overwrapping film.
  • Ensure uniform wrapping without air gaps or wrinkles.
  • 5.3 Shrink-Wrapping Process

    • Feed the overwrapped products into the shrink-wrapping tunnel.
    • Set the temperature and speed parameters of the shrink-wrapping machine.
    • Ensure that shrink-wrapping evenly adheres to the product without causing deformation.
    • Perform random checks for proper seal formation and wrapping integrity.

    5.4 Quality Inspection

    • Conduct visual inspection to ensure no torn or improperly sealed wraps.
    • Ensure that batch numbers and expiry dates remain visible after shrink-wrapping.
    • QA must verify that wrapped products meet specifications before final approval.

    5.5 Handling of Defective Wrapping

    • Identify and segregate improperly wrapped units.
    • Document and investigate the cause of wrapping defects.
    • Reprocess or discard defective wrapped products as per QA decision.

    5.6 Documentation and Review

    • Record shrink-wrapping details in the Packaging Log.
    • QA must review and approve the final wrapped batch before storage or dispatch.
    • Ensure traceability of wrapped batches for regulatory compliance.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • BPR – Batch Packaging Record

    7. Documents

    • Overwrapping and Shrink-Wrapping Inspection Log (Annexure-1)
    • Final Shrink-Wrapping Approval Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • ICH Q10 – Pharmaceutical Quality System
    • USP <41> – Weights and Balances

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Overwrapping and Shrink-Wrapping Inspection Log

    Date Batch Number Wrapping Type Inspected By Result Remarks
    01/02/2025 OINT-101 Shrink-Wrap QA Officer Pass Compliant
    01/02/2025 OINT-102 Overwrap QA Officer Pass Compliant

    Annexure-2: Final Shrink-Wrapping Approval Report

    Date Batch Number Wrapping Component Verified By Approval Status
    01/02/2025 OINT-101 Shrink Film, Labels QA Manager Approved
    02/02/2025 OINT-102 Overwrap, Carton Labels QA Manager Approved

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Aerosol: SOP for Gas Filling in Aerosol Cans – V 2.0
    Next Post: Tablets: SOP for Acid Resistance Testing for Enteric-Coated Tablets – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version